Cargando…
Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L
SARS-CoV-2 requires serine protease, transmembrane serine protease 2 (TMPRSS2), and cysteine proteases, cathepsins B, L (CTSB/L) for entry into host cells. These host proteases activate the spike protein and enable SARS-CoV-2 entry. We herein performed genomic-guided gene set enrichment analysis (GS...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372896/ https://www.ncbi.nlm.nih.gov/pubmed/34407143 http://dx.doi.org/10.1371/journal.pone.0256141 |
_version_ | 1783739849519398912 |
---|---|
author | Prasad, Kartikay AlOmar, Suliman Yousef Almuqri, Eman Abdullah Rudayni, Hassan Ahmed Kumar, Vijay |
author_facet | Prasad, Kartikay AlOmar, Suliman Yousef Almuqri, Eman Abdullah Rudayni, Hassan Ahmed Kumar, Vijay |
author_sort | Prasad, Kartikay |
collection | PubMed |
description | SARS-CoV-2 requires serine protease, transmembrane serine protease 2 (TMPRSS2), and cysteine proteases, cathepsins B, L (CTSB/L) for entry into host cells. These host proteases activate the spike protein and enable SARS-CoV-2 entry. We herein performed genomic-guided gene set enrichment analysis (GSEA) to identify upstream regulatory elements altering the expression of TMPRSS2 and CTSB/L. Further, medicinal compounds were identified based on their effects on gene expression signatures of the modulators of TMPRSS2 and CTSB/L genes. Using this strategy, estradiol and retinoic acid have been identified as putative SARS-CoV-2 alleviation agents. Next, we analyzed drug-gene and gene-gene interaction networks using 809 human targets of SARS-CoV-2 proteins. The network results indicate that estradiol interacts with 370 (45%) and retinoic acid interacts with 251 (31%) human proteins. Interestingly, a combination of estradiol and retinoic acid interacts with 461 (56%) of human proteins, indicating the therapeutic benefits of drug combination therapy. Finally, molecular docking analysis suggests that both the drugs bind to TMPRSS2 and CTSL with the nanomolar to low micromolar affinity. The results suggest that these drugs can simultaneously target both the entry pathways of SARS-CoV-2 and thus can be considered as a potential treatment option for COVID-19. |
format | Online Article Text |
id | pubmed-8372896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-83728962021-08-19 Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L Prasad, Kartikay AlOmar, Suliman Yousef Almuqri, Eman Abdullah Rudayni, Hassan Ahmed Kumar, Vijay PLoS One Research Article SARS-CoV-2 requires serine protease, transmembrane serine protease 2 (TMPRSS2), and cysteine proteases, cathepsins B, L (CTSB/L) for entry into host cells. These host proteases activate the spike protein and enable SARS-CoV-2 entry. We herein performed genomic-guided gene set enrichment analysis (GSEA) to identify upstream regulatory elements altering the expression of TMPRSS2 and CTSB/L. Further, medicinal compounds were identified based on their effects on gene expression signatures of the modulators of TMPRSS2 and CTSB/L genes. Using this strategy, estradiol and retinoic acid have been identified as putative SARS-CoV-2 alleviation agents. Next, we analyzed drug-gene and gene-gene interaction networks using 809 human targets of SARS-CoV-2 proteins. The network results indicate that estradiol interacts with 370 (45%) and retinoic acid interacts with 251 (31%) human proteins. Interestingly, a combination of estradiol and retinoic acid interacts with 461 (56%) of human proteins, indicating the therapeutic benefits of drug combination therapy. Finally, molecular docking analysis suggests that both the drugs bind to TMPRSS2 and CTSL with the nanomolar to low micromolar affinity. The results suggest that these drugs can simultaneously target both the entry pathways of SARS-CoV-2 and thus can be considered as a potential treatment option for COVID-19. Public Library of Science 2021-08-18 /pmc/articles/PMC8372896/ /pubmed/34407143 http://dx.doi.org/10.1371/journal.pone.0256141 Text en © 2021 Prasad et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Prasad, Kartikay AlOmar, Suliman Yousef Almuqri, Eman Abdullah Rudayni, Hassan Ahmed Kumar, Vijay Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title | Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title_full | Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title_fullStr | Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title_full_unstemmed | Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title_short | Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L |
title_sort | genomics-guided identification of potential modulators of sars-cov-2 entry proteases, tmprss2 and cathepsins b/l |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372896/ https://www.ncbi.nlm.nih.gov/pubmed/34407143 http://dx.doi.org/10.1371/journal.pone.0256141 |
work_keys_str_mv | AT prasadkartikay genomicsguidedidentificationofpotentialmodulatorsofsarscov2entryproteasestmprss2andcathepsinsbl AT alomarsulimanyousef genomicsguidedidentificationofpotentialmodulatorsofsarscov2entryproteasestmprss2andcathepsinsbl AT almuqriemanabdullah genomicsguidedidentificationofpotentialmodulatorsofsarscov2entryproteasestmprss2andcathepsinsbl AT rudaynihassanahmed genomicsguidedidentificationofpotentialmodulatorsofsarscov2entryproteasestmprss2andcathepsinsbl AT kumarvijay genomicsguidedidentificationofpotentialmodulatorsofsarscov2entryproteasestmprss2andcathepsinsbl |